Novassay is developing a neuropathic pain therapeutic and going to phase two clinical trials in Q2 2021. Raised Euro 9M (founder and grant from Eurostars); seeking US$12.5 M.

Vista Global Capital if Toronto, Canada has been engaged as Capital Advisor, Carmichael Casinader, Managing Partner and Novassay’s founder Dr. George Skouteris are available for a call.

Carmichael’s contact information:
carmichael@vistaglobalcapital.com
416-605-9067